Clinical Trial Results: Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 trial results report pharmacokinetics, safety, and tolerability of ITF2357 in participants with chronic hepatic impairment compared to those with normal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment
• Liver Disease

Drugs mentioned

• ITF2357 (ITF2357)

Snippet

Sponsor: Italfarmaco | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2026-06-18